StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) income statement

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.12−0.06 (-1.89%)

Close on Nov 18, 2026Market cap $777.47MP/E –Yield –

Ardelyx, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
94.4%
Operating margin
-7.9%
Net margin
-12.4%
Return on equity, FY2025
-36.2%

Financial strength

Current ratio
3.34
Debt to equity
–
Debt to assets
–
Cash to current liabilities
73.5%

Valuation

P/E ratio
–
Price to sales
1.72
Price to book
5.22
Dividend yield
–

See a number that looks wrong?